v3.26.1
Other Assets
3 Months Ended
Mar. 31, 2026
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Other Assets Other Assets
The following table presents the components of the Company’s Other assets at March 31, 2026 and December 31, 2025:

(In Thousands)March 31, 2026December 31, 2025
REO$138,651 $135,035 
Commercial REO12,237 19,885 
Goodwill61,076 61,076 
Intangibles, net (1)
2,300 2,600 
Capital contributions made to loan origination partners20,587 20,182 
Commercial loans4,510 6,079 
Interest receivable109,773 111,118 
Other loan related receivables8,072 8,874 
Lease right-of-use asset (2)
9,604 42,810 
Other82,371 81,488 
Total Other Assets$449,181 $489,147 
(1)Net of aggregate accumulated amortization of $25.7 million and $25.4 million as of March 31, 2026 and December 31, 2025, respectively.
(2)An estimated incremental borrowing rate of 6.5% and 7.5% was used in connection with the Company’s primary operating lease as of March 31, 2026 and December 31, 2025, respectively, and an estimated incremental borrowing rate of 8.0% was used in connection with Lima One’s headquarters lease (see Notes 2 and 9).
(a) Real Estate Owned and Commercial REO

The following table summarizes the aggregate carrying value of REO properties by loan source prior to foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement.

(Dollars In Thousands)March 31, 2026December 31, 2025
Non-QM loans$12,192 $12,066 
Business purpose loans79,791 80,822 
Legacy RPL/NPL loans46,668 42,147 
Total$138,651 $135,035 
Number of properties302 322 
At March 31, 2026, $138.7 million of residential real estate property was held by the Company that was acquired either through a completed foreclosure proceeding or from completion of a deed-in-lieu of foreclosure or similar legal agreement. In addition, formal foreclosure proceedings were in process with respect to $42.5 million of residential whole loans held at carrying value and $216.0 million of residential whole loans held at fair value at March 31, 2026.

The following table presents the activity in the Company’s REO for the three months ended March 31, 2026 and 2025:
Three Months Ended
March 31,
(Dollars In Thousands)20262025
Balance at beginning of period$135,035 $130,854 
Adjustments to record at lower of cost or fair value(4,018)(3,213)
Transfer from residential whole loans (1)
25,252 25,448 
Purchases and capital improvements, net25 136 
Disposals and other (2)
(17,643)(22,591)
Balance at end of period$138,651 $130,634 
Number of properties302 402 
(1)During the three months ended March 31, 2026 and 2025, the Company recognized $(0.2) million and $0.0 million of gains/(losses), respectively, on Residential whole loans in Other Income/(Loss), net associated with the transfer of loans to REO.
(2)During the three months ended March 31, 2026 and 2025, the Company sold 68 and 94 REO properties for consideration of $18.2 million and $24.2 million, realizing net gains of approximately $0.6 million and $1.7 million, respectively. These amounts are included in Other Income/(Loss), net on the Company’s consolidated statements of operations.
Commercial REO

In the third quarter of 2024, the Company received 75% and 49% interests, respectively, in two VIEs through foreclosure of a multifamily property and a senior living facility underlying delinquent commercial mortgage loans. Each of these entities was determined to be a VIE but the Company was not determined to be the primary beneficiary; as a result, the investments in the entities are considered equity method investments. Each entity accounts for its respective commercial REO property (the “Commercial REO”) similarly to the manner in which the Company accounts for its residential REO. The entities generally do not own any other significant assets or carry any significant liabilities, except that the two entities contain properties encumbered by third-party financing. As of December 31, 2025, one property was considered held-for-investment and one property was considered held-for-sale. During the three months ended March 31, 2026, the senior living facility property considered held-for-sale was sold for net proceeds of $17.4 million, with the Company’s share of the net realized gain totaling $0.4 million.
(b) Goodwill and Intangible Assets

On July 1, 2021, the Company completed the acquisition of Lima One. In connection with the acquisition of Lima One, the Company identified and recorded goodwill of $61.1 million and finite-lived intangible assets totaling $28.0 million. For the Lima One reporting unit, through the most recent testing date (October 1, 2025), no impairment has been recorded since the goodwill was initially recognized as the estimated fair value of the reporting unit has consistently exceeded its carrying value. Key assumptions used in the valuation included loan origination volume, expense levels, discount rates and capitalization multiples, all of which are subject to variability in the current market.
The amortization period for each of the finite lived intangible assets and the activity for the three months ended March 31, 2026 is summarized in the table below:
(Dollars in Thousands)Carrying Value at December 31, 2025Amortization
Three months ended March 31, 2026
Carrying Value at March 31, 2026
Amortization Period (Years) (1)
Trademarks / Trade Names$2,200 $(100)$2,100 10
Internally Developed Software400 (200)200 5
Total Identified Intangibles$2,600 $(300)$2,300 
(1)Amortization is calculated on a straight-line basis over the amortization period.
(c) Capital Contributions Made to Loan Origination Partners

The Company has made investments in several loan originators as part of its strategy to be a reliable source of capital to select partners from whom the Company sources residential mortgage loans through both flow arrangements and bulk purchases. At March 31, 2026, the carrying value of these investments (including adjustments for impairments or mark-to-market changes) was $20.6 million, including $5.5 million of common equity (including partnership interests) and $15.1 million of preferred equity.

During the three months ended March 31, 2026 and 2025, there were no impairment charges recorded by the Company on its investments in loan origination partners.

Prior to December 31, 2024, the Company had elected to account for certain of these investments pursuant to the fair value option, where changes in estimated fair value were recorded on the statement of operations. Such changes in estimated fair value resulted in gains (losses) being recorded of $0.4 million and $0.8 million during the three months ended March 31, 2026 and 2025, respectively.

For certain of the Company’s investments, the interests acquired to date by the Company generally do not have a readily determinable fair value. Consequently, the Company accounts for these interests (including any acquired options and warrants) in loan originators initially at cost. The carrying value of these investments will be adjusted if it is determined that an impairment has occurred or if there has been a subsequent observable transaction in either the investee company’s equity securities or a similar security that provides evidence to support an adjustment to the carrying value. In addition, for certain partners, options or warrants have also been acquired that provide the Company the ability to increase the level of its investment if certain conditions are met. At the end of each reporting period, or earlier if circumstances warrant, the Company evaluates whether the nature of its interests and other involvement with the investee entity requires the Company to apply equity method accounting or consolidate the results of the investee entity with the Company’s financial results.
(d) Commercial Mortgage Loans

As of December 31, 2025, the Company owned two participations in commercial mortgage bridge loans, which are accounted for at fair value under the fair value option, and are classified as Level 3 fair value measurements in the fair value hierarchy. Each of the participations is 75% of the total UPB of the related loans and the remaining interest in each loan was retained by the originator of such loan. The commercial mortgage loans are collateralized by one multifamily property and one office property. The commercial mortgage loans are first liens and bear variable interest rates. During the three months ended March 31, 2026, the commercial mortgage loan secured by the office property was sold for $1.6 million, realizing losses, before the impact of the reversal of previously recognized unrealized losses, of $2.8 million. Upon sale, the Company reversed $3.0 million of previously recognized unrealized losses, resulting in a net gain on sale of $0.2 million. Only the commercial mortgage loan secured by the multifamily property remains as of March 31, 2026.
The following table presents certain additional information about the Company’s commercial mortgage loans as of March 31, 2026 and December 31, 2025:
(Dollars In Thousands)Fair Value / Carrying ValueUPB
Weighted Average Coupon (1)
Weighted Average Term to Maturity (Months)UPB 60+ Days DelinquentWeighted Average LTV Ratio
Commercial Loans - March 31, 2026$4,510 $4,510 10.58 %0$4,510 80 %
Commercial Loans - December 31, 2025$6,079 $9,385 10.60 %0$9,385 189 %
(1)Commercial Loans contain contractual features which increase the loan’s interest rate following an event of default. The weighted average coupon presented is calculated based on each loan’s coupon rate without regard to post-default rate adjustments.
(e) Derivative Instruments
 
Swaps

The Company’s derivative instruments include both interest rate swap agreements and ERIS swap futures, which are used to economically hedge the interest rate risk associated with certain borrowings. Pursuant to these arrangements, the Company agreed to pay a fixed rate of interest and receive a variable interest rate, generally based on the Secured Overnight Financing Rate (“SOFR”), on the notional amount of the Swap. At March 31, 2026, none of the Company’s Swaps were designated as hedges for accounting purposes.

Variation margin payments on the Company’s Swaps are treated as a legal settlement of the exposure under the related Swap contract, the effect of which reduces what would have otherwise been reported as the fair value of the Swap, generally to zero.

The following table presents the assets pledged as collateral against the Company’s Swaps:
(In Thousands)March 31,
2026
December 31,
2025
Agency MBS, at fair value
$30,693 $32,015 
Restricted Cash31,683 24,317 
 
As of March 31, 2026, the Company had Swaps with an aggregate notional amount of $5.2 billion and an average maturity of approximately 49 months with a maximum term of approximately 120 months. The following table presents information about the Company’s Swaps at March 31, 2026 and December 31, 2025:
 March 31, 2026December 31, 2025
Maturity (1)
 Notional Amount (2)
Weighted Average Fixed-Pay Interest Rate
Weighted Average Variable Interest Rate (3)
Notional Amount (2)
Weighted Average Fixed-Pay Interest Rate
 Weighted Average Variable Interest Rate (3)
(Dollars in Thousands)      
Within 30 days$— — %— %$— — %— %
Over 30 days to 3 months— — — — — — 
Over 3 months to 6 months— — — — — — 
Over 6 months to 12 months1,300,000 1.42 3.68 450,000 1.12 3.87 
Over 12 months to 24 months215,000 2.93 3.68 1,065,000 1.85 3.87 
Over 24 months to 36 months415,000 3.24 3.68 341,500 3.23 3.87 
Over 36 months to 48 months332,800 2.96 3.68 332,800 2.96 3.87 
Over 48 months to 60 months1,710,200 3.32 3.68 1,463,900 3.36 3.87 
Over 60 months to 72 months— — — — — — 
Over 72 months1,192,600 3.48 3.68 827,300 3.36 3.87 
Total Swaps$5,165,600 2.83 %3.68 %$4,480,500 2.74 %3.87 %
(1)Each maturity category reflects contractual amortization and/or maturity of notional amounts.
(2)As of March 31, 2026, the aggregate notional amounts of Swaps include $2.1 billion of interest rate swap agreements and $3.1 billion of ERIS swap futures. As of December 31, 2025, the aggregate notional amounts of Swaps include $2.1 billion of interest rate swap agreements and $2.4 billion of ERIS swap futures.
(3)Reflects the benchmark variable rate due from the counterparty at the date presented. This rate adjusts daily based on SOFR. 
Impact of Derivative Instruments on Earnings

The following table presents the components of Net gain/(loss) on derivatives used for risk management purposes, which is presented in Other Income/(Loss), net in the consolidated statements of operations:
Three Months Ended March 31,
 (In Thousands)20262025
Income on Swaps variable receive leg$43,409 $34,078 
Expense on Swaps fixed pay leg(32,365)(18,824)
Unrealized mark-to-market gain/(loss)26,767 (44,842)
Net price alignment expense on margin collateral received(326)(1,467)
Realized gain/(loss) on terminated Swaps(6,759)— 
Total Net gain/(loss) on derivatives used for risk management purposes$30,726 $(31,055)
TBA Securities
The Company entered into long positions in certain TBA securities in order to acquire Agency MBS. The table below summarizes open long positions in TBA securities as of March 31, 2026, which had an aggregate value of $1.3 million and were included in Other assets on the Company’s consolidated balance sheets. The Company did not have any open positions in TBA securities at December 31, 2025. During the three months ended March 31, 2026, the Company recognized a $1.3 million unrealized gain in Other income/(loss) related to changes in fair value.
 March 31, 2026December 31, 2025
(Dollars in thousands)
 Notional Amount
Settlement Date
Notional Amount
Settlement Date
TBA Security
    
MBS 30 year 5.0% coupon
$150,000 4/13/2026$— — 
MBS 30 year 5.5% coupon
$150,000 4/13/2026$— —